Trellus Management Company, LLC Atara Biotherapeutics, Inc. Transaction History

Trellus Management Company, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 13, 2022	BUY	$4.69 - $9.84 $70,350 - $147,600	15,000 Added 15.79%	110,000 $857,000
Q4 2021 Jan 31, 2022	SELL	$14.7 - $19.89 $148,470 - $200,889	-10,100 Reduced 9.61%	95,000 $1.5 Million
Q3 2021 Oct 26, 2021	BUY	$11.99 - $17.9 $384,207 - $573,587	32,044 Added 43.86%	105,100 $1.88 Million
Q2 2021 Jul 30, 2021	BUY	$12.89 - $16.58 $812,791 - $1.05 Million	63,056 Added 630.56%	73,056 $1.14 Million
Q1 2021 May 03, 2021	SELL	$14.0 - $20.72 $166,600 - $246,568	-11,900 Reduced 54.34%	10,000 $144,000
Q4 2020 Feb 10, 2021	SELL	$12.67 - $26.23 $1.69 Million - $3.49 Million	-133,100 Reduced 85.87%	21,900 $430,000
Q3 2020 Oct 20, 2020	BUY	$11.92 - $15.87 $59,600 - $79,350	5,000 Added 3.33%	155,000 $2.01 Million
Q2 2020 Aug 12, 2020	BUY	$7.53 - $14.93 $301,200 - $597,200	40,000 Added 36.36%	150,000 $2.19 Million
Q1 2020 May 06, 2020	BUY	$5.69 - $17.78 $125,902 - $393,418	22,127 Added 25.18%	110,000 $936,000
Q4 2019 Feb 20, 2020	BUY	$10.89 - $16.79 $303,536 - $467,987	27,873 Added 46.46%	87,873 $1.45 Million
Q3 2019 Nov 01, 2019	BUY	$12.03 - $19.94 $421,050 - $697,900	35,000 Added 140.0%	60,000 $847,000
Q2 2019 Jul 31, 2019	BUY	$19.05 - $41.04 $476,250 - $1.03 Million	25,000 New	25,000 $503,000

2.89M

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $1.08B
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

Get notified when there are updates to the investment portfolio of Trellus Management Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Trellus Management Company, LLC with notifications on news.